Genesis Metabolics

Genesis Metabolics operates as a telehealth-focused obesity medicine clinic serving patients throughout New Jersey from its Union base, led by Dr. Scott DiGiacomo. The practice centers on medical weight management through evidence-based pharmacotherapy combined with structured nutritional guidance and behavioral modification strategies. Unlike surgical weight loss centers, Genesis Metabolics provides non-invasive interventions designed for patients seeking alternatives to bariatric procedures or those who require medical management of obesity-related conditions including type 2 diabetes and hypertension.

The clinic's pharmacological approach features GLP-1 receptor agonist therapies, specifically semaglutide and tirzepatide, both FDA-approved medications that work by regulating appetite, slowing gastric emptying, and improving glycemic control. Dr. DiGiacomo prescribes these peptide-based treatments as part of individualized protocols that account for each patient's metabolic profile, comorbidities, and weight loss objectives. Patients receive ongoing medication management with dosage adjustments based on response and tolerance, ensuring therapeutic effectiveness while minimizing adverse effects. The clinic's model integrates these pharmaceutical interventions with concurrent nutritional counseling, recognizing that sustainable weight reduction requires both pharmacological support and lifestyle restructuring.

Dr. Scott DiGiacomo brings specialized training in obesity medicine to his practice at Genesis Metabolics, applying clinical protocols that address the physiological mechanisms underlying weight regulation rather than relying solely on caloric restriction. His approach acknowledges obesity as a chronic metabolic disease requiring medical treatment, not simply a matter of willpower. The practice includes access to nutritionists who develop meal planning strategies tailored to individual dietary preferences, cultural considerations, and metabolic needs. Behavioral therapy components address psychological factors that influence eating patterns, stress-related consumption, and long-term adherence to lifestyle modifications.

Patients initiating care at Genesis Metabolics begin with a comprehensive telehealth consultation during which Dr. DiGiacomo reviews medical history, current medications, previous weight loss attempts, and obesity-related health conditions such as hypertension, prediabetes, or established diabetes. Laboratory evaluation typically precedes treatment initiation to establish baseline metabolic parameters. The clinic's virtual care model allows New Jersey residents to access specialized obesity medicine without geographic constraints, with follow-up appointments conducted via secure video platforms. Patients receive prescriptions electronically and coordinate medication delivery through partner pharmacies. Regular monitoring includes weight tracking, side effect assessment, and adjustment of both pharmacotherapy and nutritional plans based on progress.

Genesis Metabolics distinguishes itself through its integration of multiple therapeutic modalities under physician supervision, avoiding the single-intervention approach common in commercial weight loss programs. The clinic's focus on patients with obesity-related comorbidities means treatment plans often yield improvements in blood pressure control, glycemic management, and reduction of diabetes medications alongside weight reduction. Dr. DiGiacomo's practice model emphasizes physician-directed care throughout the weight loss process rather than delegation to non-physician providers, ensuring medical oversight of complex cases involving polypharmacy or multiple metabolic conditions. The telehealth structure provides accessibility for patients in Union and throughout New Jersey who require ongoing medical management but face barriers to frequent in-person visits.